The university of Texas acquires Leksell Gamma Knife Perfexion for targeted brain lesion treatments

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Leadership at NHS Hospitals in Leeds...

A watchdog has gone on to say that the...

Developing Dr. CaBot, A Medical Education...

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for...

The medicines regulator of the UK has announced plans...

The University of Texas M. D. Anderson Cancer Center will add Elekta’s Leksell Gamma Knife® Perfexion™, an advanced radiosurgery device specifically designed to treat one or more lesions in the head in a single session, to their radiation oncology department.

Eric Chang says, Leksell Gamma Knife Perfexion suits our clinical needs. The device will be used initially to treat primary brain and skull base tumors as well as single and multiple brain metastases in a single session.

Designed to extend the system’s reach down to the level of the skull base and cervical spine, Perfexion is scheduled to be delivered to M. D. Anderson by March 2009 and should be operational by mid-2009, he adds. 

Joseph K. Jachinowski, President and CEO of Elekta North America said, Elekta is committed to supporting radiosurgery and neuro-oncology by providing highly refined tools that support specific clinical objectives, yet share a common foundation in terms of image and information management.

Latest stories

Related stories

Developing Dr. CaBot, A Medical Education Tool That Reasons

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for Medtech Regulatory Reforms

The medicines regulator of the UK has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »